5-chloropyrazinamide has been researched along with 1-(4-nitrophenyl)piperazine in 1 studies
| Studies (5-chloropyrazinamide) | Trials (5-chloropyrazinamide) | Recent Studies (post-2010) (5-chloropyrazinamide) | Studies (1-(4-nitrophenyl)piperazine) | Trials (1-(4-nitrophenyl)piperazine) | Recent Studies (post-2010) (1-(4-nitrophenyl)piperazine) |
|---|---|---|---|---|---|
| 14 | 0 | 7 | 5 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Huang, S; Li, L; Li, W; Sun, W; Tian, C; Yang, S | 1 |
1 other study(ies) available for 5-chloropyrazinamide and 1-(4-nitrophenyl)piperazine
| Article | Year |
|---|---|
Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
Topics: Aniline Compounds; Dose-Response Relationship, Drug; Drug Discovery; Histone Deacetylase Inhibitors; Humans; Molecular Structure; Piperazine; Sirtuins; Structure-Activity Relationship | 2020 |